The expression of TOP2A in cancer tissues such as kidney cancer, liver cancer, and breast cancer were significantly higher than that in normal tissues, and TOP2A gene expression was highest in hepatocellular carcinoma stage III (Additional file 1: Fig. S1). This evidence concerns the gene TOP2A and liver cancer.